Analysts expect athenahealth, Inc. (NASDAQ:ATHN) to post $0.64 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Twenty One analysts have issued estimates for athenahealth’s earnings. The highest EPS estimate is $0.77 and the lowest is $0.57. athenahealth reported earnings of $0.62 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 3.2%. The company is expected to announce its next quarterly earnings results on Thursday, February 1st.

On average, analysts expect that athenahealth will report full-year earnings of $2.03 per share for the current year, with EPS estimates ranging from $1.95 to $2.15. For the next fiscal year, analysts anticipate that the business will post earnings of $2.87 per share, with EPS estimates ranging from $2.50 to $3.46. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that follow athenahealth.

athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. The firm had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company’s revenue was up 10.1% on a year-over-year basis. During the same period last year, the firm posted $0.60 EPS.

A number of analysts recently weighed in on ATHN shares. Oppenheimer reiterated a “buy” rating and set a $184.00 price target on shares of athenahealth in a research note on Friday, October 20th. Piper Jaffray Companies reiterated a “buy” rating and set a $167.00 price target on shares of athenahealth in a research note on Tuesday, October 17th. SunTrust Banks reiterated a “buy” rating and set a $156.00 price target on shares of athenahealth in a research note on Wednesday, October 25th. Robert W. Baird decreased their price target on shares of athenahealth from $170.00 to $155.00 and set an “outperform” rating for the company in a research note on Sunday, October 22nd. Finally, Jefferies Group set a $110.00 price target on shares of athenahealth and gave the stock a “hold” rating in a research note on Friday, October 13th. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and eleven have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $143.29.

athenahealth (ATHN) traded down $0.38 during midday trading on Wednesday, hitting $131.47. 194,300 shares of the company were exchanged, compared to its average volume of 569,885. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. The stock has a market cap of $5,276.33, a P/E ratio of 111.74, a price-to-earnings-growth ratio of 4.95 and a beta of 1.57. athenahealth has a 1 year low of $92.38 and a 1 year high of $158.66.

In other athenahealth news, insider Daniel P. Haley sold 1,583 shares of the firm’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $124.56, for a total transaction of $197,178.48. Following the completion of the transaction, the insider now directly owns 13,408 shares in the company, valued at approximately $1,670,100.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $130.38, for a total transaction of $39,114.00. The disclosure for this sale can be found here. Insiders sold 9,283 shares of company stock valued at $1,175,908 in the last quarter. Company insiders own 3.20% of the company’s stock.

Large investors have recently bought and sold shares of the business. Elliott Management Corp purchased a new position in athenahealth during the 2nd quarter valued at about $52,706,000. UBS Asset Management Americas Inc. grew its holdings in shares of athenahealth by 33.2% during the second quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock worth $4,292,000 after buying an additional 7,605 shares in the last quarter. Scout Investments Inc. grew its holdings in shares of athenahealth by 67.2% during the second quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock worth $16,256,000 after buying an additional 46,507 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of athenahealth by 1.7% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock worth $10,249,000 after buying an additional 1,222 shares in the last quarter. Finally, Rockefeller Financial Services Inc. grew its holdings in shares of athenahealth by 293.2% during the third quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock worth $1,133,000 after buying an additional 6,793 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/13/athenahealth-inc-athn-expected-to-announce-earnings-of-0-64-per-share.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.